Advisor Group Holdings, Inc. Durect Corp Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$0.38 - $0.64 $8 - $14	23 Added 0.06%	38,431 $18,000
Q1 2022 May 04, 2022	SELL	$0.55 - $0.98 $17,742 - $31,613	-32,259 Reduced 45.65%	38,408 $26,000
Q2 2021 Aug 02, 2021	BUY	$1.6 - $2.02 $1,832 - $2,312	1,145 Added 1.65%	70,667 $116,000
Q1 2021 May 13, 2021	BUY	$1.86 - $2.87 $7,108 - $10,969	3,822 Added 5.82%	69,522 $138,000
Q4 2020 Feb 10, 2021	BUY	$1.65 - $2.43 $1,130 - $1,664	685 Added 1.05%	65,700 $135,000
Q1 2020 May 18, 2020	BUY	$0.97 - $2.85 $63,064 - $185,292	65,015 New	65,015 $101,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $173M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.